Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Giosafat Spitaleri"'
Autor:
Pau Codina, Mar Domingo, Elena Barceló, Paloma Gastelurrutia, Daniel Casquete, Joan Vila, Omar Abdul‐Jawad Altisent, Giosafat Spitaleri, Germán Cediel, Evelyn Santiago‐Vacas, Elisabet Zamora, María Ruiz‐Cueto, Javier Santesmases, Rafael de laEspriella, Domingo A. Pascual‐Figal, Julio Nuñez, Josep Lupón, Antoni Bayes‐Genis
Publikováno v:
ESC Heart Failure, Vol 9, Iss 4, Pp 2170-2180 (2022)
Abstract Aims Prior studies have not fully characterized the haemodynamic effects of the angiotensin receptor‐neprilysin inhibitor (ARNI) sacubitril/valsartan in heart failure with preserved ejection fraction and pulmonary hypertension (HFpEF–PH)
Externí odkaz:
https://doaj.org/article/78636c2b72914bf0875beb6655b7bc17
Autor:
Mar Domingo, Josep Lupón, Nicolas Girerd, Laura Conangla, Marta deAntonio, Pedro Moliner, Evelyn Santiago‐Vacas, Pau Codina, German Cediel, Giosafat Spitaleri, Beatriz González, Violeta Diaz, Carmen Rivas, Patricia Velayos, Julio Núñez, Antoni Bayes‐Genís
Publikováno v:
ESC Heart Failure, Vol 8, Iss 6, Pp 4506-4516 (2021)
Abstract Aims In ambulatory patients with chronic heart failure (HF), congestion and decongestion assessment may be challenging. The aim of this study is to assess the value of lung ultrasound (LUS) in outpatients with HF in characterizing decompensa
Externí odkaz:
https://doaj.org/article/918bf4a1798740768b563169e52e57a3
Autor:
Antoni Bayes-Genis, Oriol Iborra-Egea, Giosafat Spitaleri, Mar Domingo, Elena Revuelta-López, Pau Codina, Germán Cediel, Evelyn Santiago-Vacas, Adriana Cserkóová, Domingo Pascual-Figal, Julio Núñez, Josep Lupón
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract The use of sodium-glucose co-transporter 2 inhibitors to treat heart failure with preserved ejection fraction (HFpEF) is under investigation in ongoing clinical trials, but the exact mechanism of action is unclear. Here we aimed to use artif
Externí odkaz:
https://doaj.org/article/25cc0ca35f374ccaaf5bcf8cbf852ee7
Autor:
Marco Masetti, Maria Francesca Scuppa, Alessio Aloisio, Laura Giovannini, Laura Borgese, Stefania Manno, Beatrice Tazza, Renato Pascale, Cecilia Bonazzetti, Natascia Caroccia, Mario Sabatino, Giosafat Spitaleri, Pierluigi Viale, Maddalena Giannella, Luciano Potena
Publikováno v:
Microorganisms, Vol 11, Iss 3, p 755 (2023)
Patients with heart transplantation (HT) have an increased risk of COVID-19 disease and the efficacy of vaccines on antibody induction is lower, even after three or four doses. The aim of our study was to assess the efficacy of four doses on infectio
Externí odkaz:
https://doaj.org/article/47e6bf2a3ba74467a0a0d810de7c5eb6
Autor:
Giosafat Spitaleri, Josep Lupón, Mar Domingo, Evelyn Santiago-Vacas, Pau Codina, Elisabet Zamora, Germán Cediel, Javier Santesmases, Crisanto Diez-Quevedo, Maria Isabel Troya, Maria Boldo, Salvador Altmir, Nuria Alonso, Beatriz González, Julio Núñez, Antoni Bayes-Genis
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract To assess mortality trends at 1 and 3 years from 2001 to 2018 in a real-life cohort of HF outpatients from different etiologies with depressed and preserved LVEF. A total of 2368 consecutive patients with HF (mean age 66.4 ± 12.9 years, 71%
Externí odkaz:
https://doaj.org/article/e5c30ec096344f0da1e3b50ea1f295d2
Autor:
Pau Codina, Elisabet Zamora, Wayne C. Levy, Elena Revuelta-López, Andrea Borrellas, Giosafat Spitaleri, Germán Cediel, María Ruiz-Cueto, Elena Cañedo, Evelyn Santiago-Vacas, Mar Domingo, David Buchaca, Isaac Subirana, Javier Santesmases, Rafael de la Espriella, Julio Nuñez, Josep Lupón, Antoni Bayes-Genis
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
ObjectivesHeart failure (HF) management has significantly improved over the past two decades, leading to better survival. This study aimed to assess changes in predicted mortality risk after 12 months of management in a multidisciplinary HF clinic.Ma
Externí odkaz:
https://doaj.org/article/f980f8633c99489c9c0f13c277afc869
Autor:
Alberto Aimo, Giosafat Spitaleri, Dari Nieri, Laura Maria Tavanti, Claudia Meschi, Giorgia Panichella, Josep Lupón, Francesco Pistelli, Laura Carrozzi, Antoni Bayes-Genis, Michele Emdin
Publikováno v:
Cardiac Failure Review, Vol 8, Iss , Pp - (2022)
Pirfenidone (PFD) slows the progression of idiopathic pulmonary fibrosis (IPF) by inhibiting the exaggerated fibrotic response and possibly through additional mechanisms, such as anti-inflammatory effects. PFD has also been evaluated in other fibrosi
Externí odkaz:
https://doaj.org/article/41f6037c08aa46eeb1f7ff900fcbd967
Autor:
Germán Cediel, Pau Codina, Giosafat Spitaleri, Mar Domingo, Evelyn Santiago-Vacas, Josep Lupón, Antoni Bayes-Genis
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 7 (2021)
Important differences in comorbidities and clinical characteristics exist between women and men with heart failure (HF). In particular, differences in the kinetics of biological circulating biomarkers—a critical component of cardiovascular care—a
Externí odkaz:
https://doaj.org/article/fe71080771f0474ba634fa8df1e7452e
Autor:
Josep Lupón, Evelyn Santiago-Vacas, Germán Cediel, Pau Codina, Mar Domingo, Elena Revuelta-López, Elisabet Zamora, Giosafat Spitaleri, Javier Santesmases, Julio Núñez, Antoni Bayes-Genis
Publikováno v:
PLoS ONE, Vol 16, Iss 5, p e0249674 (2021)
BackgroundCirculating Neprilysin (sNEP) has emerged as a potential prognostic biomarker in heart failure (HF). In PARAGON-HF benefit of sacubitril/valsartan was only observed in patients with left ventricular ejection fraction (LVEF) ≤57%. We aimed
Externí odkaz:
https://doaj.org/article/a27aa03020c4443db0b7ab99c440d057
Autor:
Giosafat Spitaleri, Elisabet Zamora, German Cediel, Pau Codina, Evelyn Santiago-Vacas, Mar Domingo, Josep Lupón, Javier Santesmases, Crisanto Diez-Quevedo, Maria Isabel Troya, Maria Boldo, Salvador Altimir, Núria Alonso, Beatriz González, Antoni Bayes-Genis
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 3, p 784 (2022)
We assessed differences in long-term all-cause and cardiovascular (CV) mortality in heart failure (HF) outpatients based on the etiology of HF. Consecutive patients admitted to the HF Clinic from August 2001 to September 2019 (N = 2587) were consider
Externí odkaz:
https://doaj.org/article/bb1c349677ae4fdd9769d481bb8a034c